HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Zhang Selected Research

HMGN2 Protein (HMGN2)

4/2018HMGN2: An Antitumor Effector Molecule of γδT Cells.
4/2018Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.
7/2016[The Role of HMGN2 in the Development of Periodontitis Dental Plaque].
7/2014HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.
4/2014HMGN2 protein inhibits the growth of infected T24 cells in vitro.
2/2014[Inhibitory effects of high mobility group chromosomal protein N2 on human tongue carcinoma transplanted in nude mice].
1/2014Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.
2/2013[Study on prohibition of high mobility group chromosomal protein N2 against human oral squamous cell carcinoma in vitro].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Zhang Research Topics

Disease

346Neoplasms (Cancer)
10/2022 - 02/2003
101Infections
05/2022 - 01/2002
80Inflammation (Inflammations)
11/2022 - 11/2003
68Neoplasm Metastasis (Metastasis)
10/2022 - 02/2003
47Breast Neoplasms (Breast Cancer)
01/2022 - 04/2003
39Carcinogenesis
07/2022 - 09/2005
36Squamous Cell Carcinoma of Head and Neck
11/2021 - 06/2005
33Hypoxia (Hypoxemia)
06/2022 - 05/2005
33Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2005
28Ovarian Neoplasms (Ovarian Cancer)
08/2022 - 01/2006
27Hepatocellular Carcinoma (Hepatoma)
06/2022 - 12/2003
27Myocardial Infarction
01/2021 - 08/2003
26Fibrosis (Cirrhosis)
11/2021 - 09/2004
24Carcinoma (Carcinomatosis)
10/2022 - 01/2006
24Necrosis
08/2022 - 06/2005
24Heart Failure
03/2022 - 01/2002
23Cognitive Dysfunction
01/2022 - 02/2012
22Stroke (Strokes)
01/2022 - 10/2008
22Wounds and Injuries (Trauma)
01/2022 - 07/2003
20Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 10/2007
19Adenocarcinoma of Lung
06/2022 - 12/2005
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 08/2004
19Papillary Thyroid Cancer
01/2022 - 01/2007
19Body Weight (Weight, Body)
04/2020 - 10/2002
18Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 10/2005
17Hypertension (High Blood Pressure)
01/2022 - 09/2002
17Hemorrhage
01/2022 - 06/2004
17Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 10/2012
17Lung Neoplasms (Lung Cancer)
01/2021 - 01/2010
16Alzheimer Disease (Alzheimer's Disease)
02/2022 - 01/2009
16Prostatic Neoplasms (Prostate Cancer)
08/2021 - 11/2004
15Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 03/2008
15Atherosclerosis
01/2021 - 03/2007
14Obesity
07/2022 - 12/2009
14Osteoporosis
04/2022 - 07/2013
14COVID-19
03/2022 - 01/2020
14Glioma (Gliomas)
01/2022 - 01/2014
14Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2008
13Ischemic Stroke
01/2022 - 01/2016
13Schizophrenia (Dementia Praecox)
01/2022 - 12/2016
13Melanoma (Melanoma, Malignant)
01/2022 - 01/2006
12Pain (Aches)
11/2022 - 07/2005
12Glioblastoma (Glioblastoma Multiforme)
07/2022 - 04/2014
12Chronic Kidney Failure (Chronic Renal Failure)
12/2021 - 07/2009
12Liver Neoplasms (Liver Cancer)
08/2021 - 12/2003
12Ischemia
01/2021 - 02/2014
11Disease Progression
12/2022 - 10/2006
11Lymphoma (Lymphomas)
07/2022 - 07/2006
10Ovarian Epithelial Carcinoma
04/2022 - 01/2006
10Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 01/2014
10Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 09/2005

Drug/Important Bio-Agent (IBA)

168Proteins (Proteins, Gene)FDA Link
09/2022 - 12/2002
79Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2007
68Pharmaceutical PreparationsIBA
07/2022 - 02/2003
51CytokinesIBA
09/2022 - 08/2004
51Messenger RNA (mRNA)IBA
09/2022 - 01/2002
37MicroRNAs (MicroRNA)IBA
08/2022 - 04/2010
28Biological ProductsIBA
01/2022 - 03/2007
27Glucose (Dextrose)FDA LinkGeneric
08/2022 - 09/2003
25Small Interfering RNA (siRNA)IBA
08/2022 - 02/2006
25Long Noncoding RNAIBA
06/2022 - 01/2015
25Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2006
23Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2003
21RNA (Ribonucleic Acid)IBA
04/2022 - 12/2006
21Therapeutic UsesIBA
03/2022 - 04/2007
21EnzymesIBA
01/2022 - 06/2009
20Insulin (Novolin)FDA Link
01/2022 - 12/2006
20DNA (Deoxyribonucleic Acid)IBA
05/2021 - 07/2005
19LipidsIBA
07/2022 - 12/2007
18VaccinesIBA
01/2022 - 12/2002
17Peptides (Polypeptides)IBA
01/2022 - 11/2005
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2002
17Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2006
16LipopolysaccharidesIBA
01/2022 - 04/2002
16Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2005
16AntigensIBA
01/2022 - 01/2002
15Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 08/2004
14Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2006
14Indicators and Reagents (Reagents)IBA
01/2022 - 01/2002
14NF-kappa B (NF-kB)IBA
01/2020 - 01/2006
13LigandsIBA
01/2022 - 01/2004
13AntibodiesIBA
11/2020 - 01/2002
12ErbB Receptors (EGF Receptor)IBA
07/2022 - 04/2008
12Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2022 - 01/2017
11Hemoglobins (Hemoglobin)IBA
01/2022 - 04/2012
11InterferonsIBA
01/2022 - 12/2006
10Phosphotransferases (Kinase)IBA
11/2022 - 09/2004
10CholesterolIBA
07/2022 - 09/2002
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2003

Therapy/Procedure

161Therapeutics
10/2022 - 04/2003
64Drug Therapy (Chemotherapy)
04/2022 - 07/2002
25Radiotherapy
06/2022 - 08/2006
23Transplantation
01/2022 - 11/2004
16Aftercare (After-Treatment)
01/2022 - 11/2006
13Immunotherapy
01/2022 - 05/2002
13Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2021 - 07/2005
12Lasers (Laser)
01/2021 - 09/2007
12Stem Cell Transplantation
01/2020 - 06/2008
11Renal Dialysis (Hemodialysis)
12/2021 - 01/2009
11Ligation
05/2016 - 08/2003